Cosmax BTI, Inc. (KRX:044820)
South Korea · Delayed Price · Currency is KRW | Market Cap | 154.12B +68.0% |
| Revenue (ttm) | 645.21B +8.0% |
| Net Income | 29.21B +77.5% |
| EPS | 3,056.00 +77.5% |
| Shares Out | 9.55M |
| PE Ratio | 5.28 |
| Forward PE | n/a |
| Dividend | 450.00 (2.81%) |
| Ex-Dividend Date | Mar 30, 2026 |
| Volume | 16,914 |
| Average Volume | 21,033 |
| Open | 16,750 |
| Previous Close | 16,010 |
| Day's Range | 15,900 - 16,810 |
| 52-Week Range | 10,130 - 24,900 |
| Beta | 0.65 |
| RSI | 59.45 |
| Earnings Date | Mar 27, 2026 |
About Cosmax BTI
Cosmax BTI, Inc. engages in the research, development, production, and sale of cosmetics, health functional foods, pharmaceuticals, and special containers in South Korea. The company offers cosmetics products, including skincare, mask, cleansing, hair, bath and body, sun care, makeup, cushion, eye and lip makeup, nail, and fragrance products; baby and child cosmetic products; Korean herbal cosmetics; and cosmeceuticals. It also provides health supplement products in form of gels, capsules, and powders; and medical devices. In addition, the comp... [Read more]
Financial Performance
In 2025, Cosmax BTI's revenue was 645.21 billion, an increase of 7.96% compared to the previous year's 597.63 billion. Earnings were 29.21 billion, an increase of 77.50%.
Financial StatementsNews
COSMAX Establishes First European Production Base with Strategic Acquisition of Italy's Keminova
– Combining K-Beauty technological expertise with Europe's clean & vegan manufacturing specialization… Strengthening the foundation of ‘Premium' – Operating production bases in six countries across As...